| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net loss | -453 | -25 | 19 | -482 |
| Depreciation | 104 | 68 | 34 | 99 |
| Amortization of intangible assets | 155 | 99 | 45 | 162 |
| Goodwill asset impairment | 409 | 156 | - | - |
| Goodwill and intangible asset impairments | - | - | - | 510 |
| Indefinite-lived intangible asset impairment | 88 | 79 | 0 | - |
| Deferred income taxes | 44 | -136 | 1 | -20 |
| Stock-based compensation expense | 25 | 19 | 10 | 35 |
| Other non-cash expense | -13 | -19 | -9 | -36 |
| Accounts and notes receivable-trade, net | 56 | 31 | 31 | -19 |
| Inventories, net | 61 | 47 | 26 | -2 |
| Prepaid expenses and other current assets | 10 | -26 | 1 | -61 |
| Other noncurrent assets | 0 | -1 | -4 | 6 |
| Accounts payable | -9 | -10 | 14 | -6 |
| Accrued liabilities | -66 | -35 | -44 | -17 |
| Income taxes | -45 | -55 | -12 | -15 |
| Other noncurrent liabilities | -4 | -73 | -15 | -4 |
| Net cash provided by operating activities | 134 | 55 | 7 | 374 |
| Capital expenditures | 90 | 51 | 19 | 129 |
| Cash received on derivative contracts | 10 | 1 | 1 | 0 |
| Cash paid on derivative contracts | 9 | 2 | - | 12 |
| Proceeds from sale of property, plant, and equipment | - | 1 | 1 | - |
| Other investing activities | -2 | - | - | -1 |
| Net cash used in investing activities | -87 | -51 | -17 | -140 |
| Cash paid for treasury stock | 0 | 0 | - | 250 |
| Proceeds from 364-day bridge loan | 435 | 435 | 435 | - |
| Repayment of 364-day bridge loan | 435 | 435 | - | - |
| Proceeds on short-term borrowings | - | - | - | 99 |
| (repayments) proceeds on other short-term borrowings, net | -416 | -413 | -272 | - |
| Cash dividends paid | 96 | 64 | 32 | 95 |
| Proceeds from long-term borrowings | 551 | 550 | - | 0 |
| Repayments on long-term borrowings | 3 | 2 | 2 | 8 |
| Cash paid for deferred financing costs | 13 | 13 | 3 | - |
| Other financing activities, net | -4 | -3 | -3 | -10 |
| Net cash provided by (used in) financing activities | 19 | 55 | 123 | -264 |
| Effect of exchange rate changes on cash and cash equivalents | 25 | 28 | 13 | -8 |
| Net increase (decrease) in cash and cash equivalents | 91 | 87 | 126 | -38 |
| Cash and cash equivalents at beginning of period | 272 | 272 | 272 | 334 |
| Cash and cash equivalents at end of period | 363 | 359 | 398 | 296 |
DENTSPLY SIRONA Inc. (XRAY)
DENTSPLY SIRONA Inc. (XRAY)